TNBI Tanke Biosciences Corp
Grain Mill Products · OTC · SEC CIK 1452011 · Fiscal year ends 12/31
Financial factors as of 2013-09-30 (2013Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-19.5%
TTM net income YoY-164.1%
TTM EPS YoY-165.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin-0.2%
Net margin-7.1%
FCF margin-27.3%
EBITDA margin2.1%
Returns
ROE-10.2%
ROA-5.7%
ROIC (approx.)-0.4%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets45.5%
Debt / equity0.12x
Current ratio1.61x
Interest coverage-0.10x
Cash quality & payout
Operating cash flow / net income2.30x
Accruals ratio7.4%
Payout ratio—
Capex / revenue10.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20122012-12-31 | FY20112011-12-31 | FY20102010-12-31 | FY2009*2009-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $28.56M | $23.83M | $20.10M | — |
| Cost of revenue | $18.62M | $15.06M | $12.70M | — |
| Gross profit | $9.94M | $8.77M | $7.40M | — |
| R&D expense | $290,691 | $246,038 | — | — |
| SG&A expense | $2.57M | $4.49M | $834,761 | — |
| Operating income | $4.53M | $1.74M | $4.37M | — |
| Interest expense | $1.45M | $1.36M | $100,265 | — |
| Pretax income | $602,591 | -$2.45M | $4.28M | — |
| Income tax | $831,597 | $681,321 | $582,493 | — |
| Net income | -$210,247 | -$3.14M | $2.74M | $2.58M |
| EBITDA | $5.17M | $2.14M | $4.51M | — |
| EPS (basic) | -0.02 | -0.24 | 0.34 | — |
| EPS (diluted) | -0.02 | -0.24 | 0.34 | — |
| Weighted avg. shares (diluted) | 13.32M | 13.08M | 10.76M | — |
| Balance sheet | ||||
| Cash & equivalents | $6.17M | $7.70M | $2.22M | $1.82M |
| Receivables | $1.99M | $1.92M | $1.77M | — |
| Inventory | $1.41M | $1.19M | $1.35M | — |
| Current assets | $22.37M | $18.91M | $7.67M | — |
| PP&E, net | $4.81M | $4.77M | $1.55M | — |
| Intangibles | $1.24M | $838,089 | $242,417 | — |
| Total assets | $28.85M | $24.89M | $13.27M | — |
| Current liabilities | $12.10M | $3.55M | $2.41M | — |
| Short-term debt | $1.27M | $785,456 | $905,975 | — |
| Long-term debt | $792,567 | $628,365 | $452,987 | — |
| Total debt | $2.06M | $1.41M | $1.36M | — |
| Total liabilities | $12.93M | $9.03M | $2.93M | — |
| Shareholders' equity | $15.75M | $15.85M | $8.16M | $6.44M |
| Net debt | -$4.11M | -$6.29M | -$863,063 | — |
| Shares outstanding | 13.32M | 13.32M | 10.76M | — |
| Cash flow statement | ||||
| Operating cash flow | -$1.18M | $3.65M | $4.38M | — |
| Capital expenditure | $856,361 | $701,022 | $76,071 | — |
| Free cash flow | -$2.04M | $2.95M | $4.31M | — |
| Investing cash flow | -$1.53M | -$3.67M | -$2.82M | — |
| Financing cash flow | $1.12M | $5.82M | -$1.22M | — |
| Depreciation & amortization | $636,286 | $400,013 | $136,140 | — |
| Stock-based compensation | — | $2.49M | $0 | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.